Twenty-four-hour urinary glucose levels during tolbutamide and glibenclamide therapy.
D000328:Adult; D001786:Blood Glucose / Q000032:analysis; D003510:Cyclohexanes / Q000627:therapeutic use; D003920:Diabetes Mellitus / Q000188:drug therapy; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*
D001786:Blood Glucose; D003510:Cyclohexanes; D007004:Hypoglycemic Agents